2 completed, 1 active not recruiting, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Placebo (blinded): new trials by email Literature Review of Placebo (blinded) trials Research Report on Placebo (blinded)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Placebo (blinded), Vancomycin (blinded), Vancomycin (open-label extension) - Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC) | Phase 2 | Recruiting | McMaster University | 14 | 2026-06-17 | 2026-10-09 |
| A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) Placebo (blinded), LX9211 (blinded) - Diabetic Peripheral Neuropathic Pain | Phase 2 | Completed | Lexicon Pharmaceuticals | 496 | 2023-11-29 | 2025-10-10 |
| Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open label) - Systemic Sclerosis, Scleroderma | Phase 3 | Active not recruiting | AstraZeneca | 314 | 2023-11-08 | 2026-09-30 |
| Dupilumab in Eosinophilic Gastritis Dupilumab (blinded), Placebo (blinded) - Eosinophilic Gastritis, Eosinophilic Gastroenteritis | Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 41 | 2021-05-15 | 2025-11-04 |
Autoimmune Diseases (1) · Cholangitis, Sclerosing (1) · Colitis, Ulcerative (1) · Eosinophilic enteropathy (1) · Immune System Diseases (1) · Lung Diseases, Interstitial (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1)
AstraZeneca (1) · Children's Hospital Medical Center, Cincinnati (1) · Lexicon Pharmaceuticals (1) · McMaster University (1)
United States (3) · Canada (2) · Austria (1) · Belgium (1) · China (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Malaysia (1) · Mexico (1) · Netherlands (1)
Marc Rothenberg (1) · Neeraj Narula, MD (1)
PMID 37753954, PMID 41217519, PMID 42341804
2023 (1), U54AI117804 (1)